Evidence map›Paper›PMID 24345356›Full record

Trial reportThe Journal of clinical psychiatry2014

A randomized trial of concurrent smoking-cessation and substance use disorder treatment in stimulant-dependent smokers.

Theresa M Winhusen, Gregory S Brigham, Frankie Kropp, Robert Lindblad, John G Gardin, Pat Penn, Candace Hodgkins, Thomas M Kelly, Antoine Douaihy, Michael McCann and 11 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of clinical psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01077024 (Smoking-Cessation and Stimulant Treatment), which is not on this map. Cited by 43 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 10 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01077024 phase3completednot on this map

Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes

TypeinterventionalSponsorUniversity of CincinnatiRan2010 to 2012Enrolled538ConditionsCocaine Dependence, Methamphetamine Dependence, Nicotine DependenceArmsSmoking-cessation treatment
3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 10 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Incentives for smoking cessation.The Cochrane database of systematic reviews · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Incentives for smoking cessation.The Cochrane database of systematic reviews · 2019
    Pooled it
  5. Competitions for smoking cessation.The Cochrane database of systematic reviews · 2019
    Pooled it
  6. Pooled it
  7. A Systematic Review of Smoking Cessation Interventions for Adults in Substance Abuse Treatment or Recovery.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2016
    Pooled it
  8. Pooled it
  9. Pooled it
  10. Guideline
  11. Prize-Based Incentives for Smoking Cessation Among People With HIV: A Sequential Multiple Assignment Randomized Trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Evaluating Nicotine Craving, Withdrawal, and Substance Use as Mediators of Smoking Cessation in Cocaine- and Methamphetamine-Dependent Patients.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2016
    Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 9 institutions in 3 countries.

Theresa M WinhusenUniversity of Cincinnati, 3210 Jefferson Ave, Cincinnati, OH 45220 winhusen@carc.uc.edu.
Gregory S Brigham
Frankie Kropp
Robert Lindblad
John G Gardin
Pat Penn
Candace Hodgkins
Thomas M Kelly
Antoine Douaihy
Michael McCann
Lee D Love
Eliot DeGravelles
Ken Bachrach
Susan C Sonne
Bob Hiott
Louise Haynes
Gaurav Sharma
Daniel F Lewis
Paul VanVeldhuisen
Jeff Theobald
Udi Ghitza
University of Cincinnati · USAlkermes (Ireland) · IEAdaptimmune (United Kingdom) · GBBehavioral Health Services · USCouncil on Alcoholism and Drug Abuse · USGateway Community Services (United States) · USMatrix Institute on Addictions · USNational Institutes of Health · USTarzana Treatment Centers · US

Funding

Project-004UG1DA020024 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI Steven J Shoptaw, MADHUKAR H. TRIVEDI · 2015 to 2026
$71.6M
FLORIDA NODE OF THE DRUG ABUSE CLINICAL TRIALS NETWORKU10DA013720 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI METSCH, LISA R, SZAPOCZNIK, JOSE · 2000 to 2015
$56.9M
The National Drug Abuse Treatment Clinical Trials NetworkU10DA013045 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LING, WALTER NMN · 1999 to 2015
$52.6M
Clinical Trials Network, Ohio Valley Node U10DA013732U10DA013732 · NIDA · UNIVERSITY OF CINCINNATI · PI WINHUSEN, T JOHN · 2000 to 2015
$45.0M
Southern Consortium Node of the Clinical Trials NetworkU10DA013727 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2000 to 2015
$34.4M
Western States Node of the National Drug Abuse Treatment Clinical Trials NetworkU10DA015815 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MCCARTY, DENNIS, SORENSEN, JAMES L · 2002 to 2015
$25.2M
Concept ProjectU10DA020024 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI TRIVEDI, MADHUKAR H. · 2005 to 2015
$22.6M
CLINICAL TRIAL RESEARCH PROJECT COREU10DA020036 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DALEY, DENNIS C · 2005 to 2015
$14.1M
NIDA NIH HHS U10 DA013045NIDA NIH HHS U10-DA013045NIDA NIH HHS U10 DA013720NIDA NIH HHS U10-DA013720NIDA NIH HHS U10 DA013727NIDA NIH HHS U10-DA013727NIDA NIH HHS U10 DA013732NIDA NIH HHS U10-DA013732NIDA NIH HHS U10 DA015815NIDA NIH HHS U10-DA015815NIDA NIH HHS U10 DA020024NIDA NIH HHS U10-DA020024NIDA NIH HHS U10 DA020036NIDA NIH HHS U10-DA020036NIDA NIH HHS UG1 DA020024
6 · The paper itself

Abstract

objectiveTo evaluate the impact of concurrent treatments for substance use disorder and nicotine-dependence for stimulant-dependent patients.

methodA randomized, 10-week trial with follow-up at 3 and 6 months after smoking quit date conducted at 12 substance use disorder treatment programs between February 2010 and July 2012. Adults meeting DSM-IV-TR criteria for cocaine and/or methamphetamine dependence and interested in quitting smoking were randomized to treatment as usual (n = 271) or treatment as usual with smoking-cessation treatment (n = 267). All participants received treatment as usual for substance use disorder treatment. Participants assigned to treatment as usual with concurrent smoking-cessation treatment received weekly individual smoking cessation counseling and extended-release bupropion (300 mg/d) during weeks 1-10. During post-quit treatment (weeks 4-10), participants assigned to treatment as usual with smoking-cessation treatment received a nicotine inhaler and contingency management for smoking abstinence. Weekly proportion of stimulant-abstinent participants during the treatment phase, as assessed by urine drug screens and self-report, was the primary outcome. Secondary measures included other substance/nicotine use outcomes and treatment attendance.

resultsThere were no significant treatment effects on stimulant-use outcomes, as measured by the primary outcome and stimulant-free days, on drug-abstinence, or on attendance. Participants assigned to treatment as usual with smoking-cessation treatment, relative to those assigned to treatment as usual, had significantly better outcomes for drug-free days at 6-month follow-up (χ(2)(1) = 4.09, P <.05), with a decrease in drug-free days from baseline of -1.3% in treatment as usual with smoking-cessation treatment and of -7.6% in treatment as usual. Participants receiving treatment as usual with smoking-cessation treatment, relative to those receiving treatment as usual, had significantly better outcomes on smoking point-prevalence abstinence (25.5% vs 2.2%; χ(2)(1) = 44.69, P < .001; OR =18.2).

conclusionsThese results suggest that providing smoking-cessation treatment to illicit stimulant-dependent patients in outpatient substance use disorder treatment will not worsen, and may enhance, abstinence from nonnicotine substance use.

trial registrationClinicalTrials.gov identifier: NCT01077024.

Indexed as

AdultAmphetamine-Related DisordersAntidepressive Agents, Second-GenerationBupropionCocaine-Related DisordersCounselingFemaleHumansMaleSmokingSmoking CessationSubstance-Related DisordersTobacco Use Cessation DevicesTreatment OutcomeAntidepressive Agents, Second-GenerationBupropion

Identifiers

PMID24345356
PMCPMC4019678
OpenAlexW1990457030

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.